Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepcidin Response to Oral Iron in Iron Overload Disorders
NCT01949467Phase 2Completed
- Sponsor
- CHU Rennes
- Start
- Feb 2014
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ferrous fumarate in Hereditary hemochromatosis type 4 (HH4), dysmetabolic iron overload syndrome, sponsored by CHU Rennes. Started Feb 2014; status: completed.
02
Drugs
ferrous fumarate
03
Conditions
Hereditary hemochromatosis type 4 (HH4)dysmetabolic iron overload syndrome
Beyond the preview
Go deeper on NCT01949467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01949467.